Issue 2   |  18 March 2021  Study Overview  The TRACK trial will evaluate whether a small dose of rivaroxaban, a blood-thinning medication, would reduce cardiovascular death or major cardiovascular events in patients with advanced stages of chronic kidney disease.

 

Issue 2   |  18 March 2021 

 

Study Overview
The TRACK trial will evaluate whether a small dose of rivaroxaban, a blood-thinning medication, would reduce cardiovascular death or major cardiovascular events in patients with advanced stages of chronic kidney disease.

Patient Recruitment

Recruiting Participants with Saiyini Pirabhahar
(St George Hospital, Australia)

 

Meet the Team

 

Progress Updates

 

 

Timeline

Database Training Login...

Passwords for the TRACK Training Database logins in the IBM Clinical Development User Guide have been updated. 
Please email the Global Project Team (tracktrial@georgeinstitute.org.au) for updated passwords.


Video coming soon...